Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Chengyi Pharmaceutical
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection
- Semi-annual Earnings Preannouncement for 2025
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
Later from Zhejiang Chengyi Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Retirement and Resignation of Senior Management Member
- Announcement on Appointment of Deputy General Manager
- Announcement on Obtainment of Drug Registration Certificate for Icosapent Ethyl Soft Capsules
- Announcement on the Company's Drug Passing Consistency Evaluation of Generic Drug
Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Chengyi Pharmaceutical